Ingenuity Systems and CHDI Announce Multi-Year Deal For Disease-Specific Knowledge Platform

Ingenuity provides state-of-the-art solution for Huntington’s disease research by integrating internal knowledge and curated disease content through IPA

Redwood City, CA – July 15, 2008 – Ingenuity Systems, the leading provider of information solutions for life science researchers, and CHDI Foundation, Inc., a non-profit organization focused on discovering and developing drugs to treat Huntington’s disease, today announced a multi-year agreement for CHDI to use IPA as a platform to integrate Ingenuity-curated information relevant to Huntington’s disease. CHDI researchers will be able to leverage this knowledge using the complete set of analysis tools and structured knowledge already available in IPA.

Ingenuity is advancing the development of disease-specific solutions by allowing organizations such as CHDI to use IPA as a platform to access both internal documents and disease-specific knowledge. This new type of solution addresses longstanding information management challenges by providing a uniform platform to capture and access diverse information resources, allowing for more efficient knowledge management and improved business value. This groundbreaking solution is made possible by the Ingenuity Ontology, which organizes and structures the knowledge in IPA and which can be applied broadly across internal information and customized with disease-specific knowledge for corporate use as well as that of academic and government institutions.

“The way organizations leverage knowledge can be a significant advantage in advancing discovery,” said Robert Pacifici, Ph.D., Chief Scientific Officer for CHDI. “Using IPA provides us with a single entry point for Huntington’s disease-specific content so that this knowledge is leveraged effectively across our organization.”

“We are excited to work with CHDI to provide them with a solution tailored to their requirements,” stated Sean Scott, SVP Commercial Operations, Ingenuity Systems. “Our customers frequently request solutions that are specific to their disease-focused research programs. We are providing CHDI with custom content, so all of their knowledge can be integrated and analyzed within a common environment. CHDI staff will have higher confidence they are utilizing all the available information to effectively formulate hypotheses, verify experimental results, and share research outcomes.”

About CHDI Foundation, Inc.
CHDI Foundation is a non-profit organization supporting an international network of academic and industrial research laboratories pursuing novel treatments for Huntington’s disease. The organization’s virtual pharma approach is designed to bring the right collaborators together to identify and address critical scientific issues and move drug candidates to clinical evaluation as quickly as possible. For more information about CHDI and its collaborative programs, please contact Bonnie Lee La Madeleine at 310.342.5524.

About Ingenuity Systems®
Ingenuity Systems is a leading provider of information solutions for the exploration, interpretation, and analysis of life science information. All of Ingenuity’s products and services have one common goal — to help life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity offers a broad and flexible range of solutions that can be tailored to needs of various clients, including academic and therapeutic area researchers, computational biologists and informatics departments, and suppliers in the life sciences industry. All of the products leverage the Ingenuity Knowledge Base, the largest data base of its kind, which houses the biological and chemical relationships extracted from scientific literature. The information is uniquely structured so scientists can ask complex biological questions to gain rapid insight into their experimental data or create relevant biological models to move forward in their research. Today, Ingenuity’s solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and Japan.